Tekturna and Requip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tekturna (aliskiren hemifumarate) and Requip (ropinirole hydrochloride). Common drug interactions include dyspnoea exertional among females and nervousness among males.

The phase IV clinical study analyzes what interactions people have when they take Tekturna and Requip. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

On Jul, 08, 2026

36 people who take Tekturna and Requip together, and have interactions are studied.

What are the common drug interactions of Tekturna and Requip, by gender? *:

female:

Dyspnoea exertional (breathlessness or shortness of breath)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Facial pain
Fall
Feeling of body temperature change
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Gout (uric acid crystals building up in the body)
Heart rate decreased
Hypotension (abnormally low blood pressure)
Ill-defined disorder

male:

Nervousness
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Anxiety
Arthralgia (joint pain)
Blood creatine increased
Cataplexy (loss of muscle tone accompanied by full conscious awareness)
Chronic kidney disease
Colon cancer
Diarrhoea
Disorientation (disability in which the senses of time, direction, and recognition of people and places)

What are the common drug interactions of Tekturna and Requip, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anger
Depression
Emotional disorder
Suicidal ideation

50-59:

Drug ineffective
Injury

60+:

Nausea (feeling of having an urge to vomit)
Dizziness
Neck pain
Nephrogenic anaemia (anaemia due to kidney disease)
Back pain
Joint injury
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Rash
Abdominal pain
Abdominal pain lower

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 22.22%
Pain: 5 people, 13.89%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.11%
Depression: 4 people, 11.11%
Fatigue (feeling of tiredness): 3 people, 8.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 8.33%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 3 people, 8.33%
Constipation: 3 people, 8.33%
Dyspnea (difficult or laboured breathing): 3 people, 8.33%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tekturna and Requip?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously